# EMR INTEGRATION PLATFORM - PENETRATION TESTING SCOPE

**Document Version:** 1.0.0
**Date:** 2025-11-11
**Status:** Ready for External Security Audit
**Classification:** CONFIDENTIAL

---

## EXECUTIVE SUMMARY

This document defines the scope, objectives, and methodology for penetration testing of the EMR Integration Platform before production deployment. The testing will focus on HIPAA-compliant healthcare data protection, API security, and infrastructure vulnerabilities.

**Pre-requisites for Testing:**
- ‚úÖ Phase 1-4 remediation complete (Week 14)
- ‚úÖ All services deployed to staging environment
- ‚úÖ TLS 1.3 configured and verified
- ‚úÖ All P0 security issues resolved
- ‚ö†Ô∏è Known issues (to be fixed before testing): See Section 8

---

## 1. SCOPE OF TESTING

### 1.1 In-Scope Systems

**Production-Equivalent Staging Environment:**
- **Base URL:** https://staging.emrtask.com
- **API Gateway:** https://api.staging.emrtask.com
- **Web Application:** https://app.staging.emrtask.com
- **Infrastructure:** AWS EKS Kubernetes Cluster (us-east-1)

**Services to Test:**
1. **API Gateway** (Port 443)
   - Authentication & Authorization (OAuth2 + JWT)
   - Rate limiting and throttling
   - Input validation and sanitization

2. **Task Service** (Internal: Port 3001)
   - Task CRUD operations
   - EMR data handling and encryption
   - Barcode verification endpoints

3. **EMR Service** (Internal: Port 3002)
   - Epic FHIR adapter
   - Cerner HL7 adapter
   - Generic FHIR adapter
   - OAuth2/SMART-on-FHIR integration

4. **Sync Service** (Internal: Port 3003)
   - Offline data synchronization
   - CRDT conflict resolution
   - WebSocket connections

5. **Handover Service** (Internal: Port 3004)
   - Shift handover workflows
   - Critical event tracking

6. **Supporting Infrastructure:**
   - PostgreSQL database (RDS)
   - Redis cache cluster
   - Kafka message broker
   - Istio service mesh

### 1.2 Out-of-Scope

‚ùå **Explicitly Excluded:**
- Production environment (testing on staging only)
- Third-party EMR systems (Epic, Cerner sandboxes)
- Mobile applications (iOS/Android) - separate security review
- Physical security and social engineering
- DoS/DDoS attacks (AWS handles at infrastructure level)
- Internal corporate networks and VPN
- CI/CD pipeline (GitHub Actions) - separate security review

### 1.3 Testing Timeline

**Proposed Schedule:**
- **Week 16 (Days 1-2):** Reconnaissance and planning
- **Week 16 (Days 3-5):** Active penetration testing
- **Week 16 (Day 5):** Findings presentation and validation
- **Week 17 (Days 1-3):** Remediation verification and re-testing

---

## 2. ATTACK SURFACE ANALYSIS

### 2.1 External Attack Surface

**Publicly Accessible Endpoints:**

| Endpoint | Protocol | Purpose | Auth Required |
|----------|----------|---------|---------------|
| `/api/v1/auth/login` | HTTPS | User authentication | No |
| `/api/v1/auth/refresh` | HTTPS | Token refresh | Yes (refresh token) |
| `/api/v1/tasks` | HTTPS | Task management | Yes (JWT) |
| `/api/v1/handovers` | HTTPS | Shift handovers | Yes (JWT) |
| `/api/v1/emr/verify` | HTTPS | EMR data verification | Yes (JWT) |
| `/api/v1/audit-logs` | HTTPS | Audit log access | Yes (JWT + ADMIN) |
| `/health` | HTTPS | Health check | No |
| `/metrics` | HTTPS | Prometheus metrics | Yes (service token) |

**TLS Configuration:**
- Minimum version: TLS 1.3
- Cipher suites: ECDHE-ECDSA-AES256-GCM-SHA384, ECDHE-RSA-AES256-GCM-SHA384
- Certificate: Let's Encrypt (auto-renewal every 90 days)
- HSTS: Enabled (max-age=31536000; includeSubDomains)

### 2.2 Internal Attack Surface

**Internal Services (service mesh only):**
- Database connections (PostgreSQL, Redis)
- Message queue (Kafka)
- Inter-service communication via Istio mTLS
- Kubernetes API server (restricted by RBAC)

### 2.3 Authentication & Authorization Surface

**Attack Vectors to Test:**
1. JWT token manipulation and forgery
2. Session fixation and hijacking
3. OAuth2 flow vulnerabilities
4. Password brute-forcing (rate limited at 10/min)
5. MFA bypass attempts
6. RBAC privilege escalation
7. CSRF token validation
8. API key enumeration

### 2.4 Data Security Surface

**PHI Data Locations:**
1. **Database:**
   - `tasks.patient_id` (indexed, encrypted at rest)
   - `tasks.emr_data` (JSONB, AES-256-GCM encrypted)
   - `audit_logs.emr_patient_id` (indexed, encrypted at rest)

2. **In-Transit:**
   - API requests/responses (TLS 1.3)
   - Inter-service communication (Istio mTLS)
   - Database connections (SSL verify-full)

3. **In-Memory:**
   - Redis cache (TLS enabled, password protected)
   - Application memory (field-level encryption)

---

## 3. TESTING OBJECTIVES

### 3.1 Primary Objectives

**P0 - Critical Security Objectives:**
1. ‚úÖ **HIPAA Compliance Validation**
   - Verify PHI encryption at rest and in transit
   - Confirm audit logging captures all PHI access
   - Test access control enforcement (RBAC)
   - Verify patient data cannot be accessed without authorization

2. ‚úÖ **Authentication Security**
   - Test OAuth2 + JWT implementation
   - Verify MFA enforcement for clinical staff
   - Test session management and timeout
   - Attempt token forgery and replay attacks

3. ‚úÖ **Authorization Security**
   - Test RBAC implementation (NURSE, DOCTOR, ADMIN, SUPERVISOR)
   - Attempt horizontal privilege escalation (access other users' data)
   - Attempt vertical privilege escalation (elevate role privileges)
   - Test department-based data isolation

4. ‚úÖ **Data Protection**
   - Verify field-level encryption for PHI
   - Test encryption key management
   - Attempt SQL injection attacks
   - Test for data leakage in error messages

5. ‚úÖ **API Security**
   - Test rate limiting effectiveness (1000 req/min/user)
   - Test input validation and sanitization
   - Verify CSRF protection
   - Test for CORS misconfigurations

### 3.2 Secondary Objectives

**P1 - High Priority:**
1. Infrastructure security (Kubernetes, service mesh)
2. Third-party dependency vulnerabilities
3. Configuration security (secrets management)
4. Logging and monitoring adequacy
5. Incident response capabilities

---

## 4. TESTING METHODOLOGY

### 4.1 OWASP Testing Framework

**OWASP Top 10 (2021) Coverage:**

| Risk | Test Coverage | Priority |
|------|---------------|----------|
| A01 - Broken Access Control | ‚úÖ Full | P0 |
| A02 - Cryptographic Failures | ‚úÖ Full | P0 |
| A03 - Injection | ‚úÖ Full | P0 |
| A04 - Insecure Design | ‚úÖ Full | P0 |
| A05 - Security Misconfiguration | ‚úÖ Full | P0 |
| A06 - Vulnerable Components | ‚úÖ Full | P1 |
| A07 - Identification/Auth Failures | ‚úÖ Full | P0 |
| A08 - Software/Data Integrity | ‚úÖ Full | P1 |
| A09 - Logging/Monitoring Failures | ‚úÖ Full | P1 |
| A10 - SSRF | ‚úÖ Full | P1 |

### 4.2 HIPAA-Specific Testing

**164.312 Technical Safeguards Verification:**

1. **Access Control (¬ß164.312(a))**
   - Test unique user identification
   - Verify emergency access procedures
   - Test automatic logoff (30-minute timeout)
   - Verify encryption and decryption

2. **Audit Controls (¬ß164.312(b))**
   - Verify all PHI access is logged
   - Test audit log integrity
   - Verify 7-year retention policy
   - Test tamper-proof audit trails

3. **Integrity (¬ß164.312(c))**
   - Test data integrity mechanisms
   - Verify checksums and signatures
   - Test against unauthorized modification

4. **Transmission Security (¬ß164.312(e))**
   - Verify TLS 1.3 enforcement
   - Test end-to-end encryption
   - Verify integrity controls

### 4.3 Testing Phases

**Phase 1: Reconnaissance (2 days)**
- Information gathering (DNS, subdomain enum, port scanning)
- Technology stack identification
- Attack surface mapping
- Authentication mechanism analysis

**Phase 2: Vulnerability Assessment (2 days)**
- Automated scanning (OWASP ZAP, Burp Suite)
- Manual code review (if provided)
- Configuration review
- Dependency vulnerability analysis

**Phase 3: Exploitation (2 days)**
- Manual exploitation of discovered vulnerabilities
- Privilege escalation attempts
- Data exfiltration simulation
- Lateral movement testing

**Phase 4: Post-Exploitation (1 day)**
- Persistence testing
- Data impact assessment
- Remediation validation
- Final report preparation

---

## 5. TESTING TOOLS

### 5.1 Authorized Tools

**Web Application Testing:**
- ‚úÖ Burp Suite Professional (latest)
- ‚úÖ OWASP ZAP
- ‚úÖ Postman/Insomnia (API testing)
- ‚úÖ SQLmap (injection testing)
- ‚úÖ Nuclei (vulnerability scanner)

**Infrastructure Testing:**
- ‚úÖ Nmap (port scanning)
- ‚úÖ Nikto (web server scanner)
- ‚úÖ SSLScan (TLS configuration)
- ‚úÖ Trivy (container scanning)

**Specialized Tools:**
- ‚úÖ JWT_Tool (JWT manipulation)
- ‚úÖ Hydra (authentication testing)
- ‚úÖ Hashcat (password analysis)
- ‚úÖ Metasploit (exploitation framework)

**Monitoring:**
- ‚úÖ Wireshark (traffic analysis)
- ‚úÖ tcpdump (packet capture)

### 5.2 Prohibited Tools

‚ùå **Do NOT Use:**
- DoS/DDoS tools (slowloris, LOIC, etc.)
- Ransomware or destructive payloads
- Actual malware samples
- Tools that cause service disruption

---

## 6. CRITICAL ENDPOINTS TO TEST

### 6.1 Authentication Endpoints

```
POST /api/v1/auth/login
POST /api/v1/auth/refresh
POST /api/v1/auth/logout
POST /api/v1/auth/mfa/verify
POST /api/v1/auth/password/reset
```

**Test Cases:**
- [ ] JWT signature verification bypass
- [ ] Token expiration enforcement (1 hour access, 30 day refresh)
- [ ] Password complexity requirements
- [ ] MFA bypass via token manipulation
- [ ] Session fixation via cookie manipulation
- [ ] CSRF token validation
- [ ] Rate limiting (10 failed attempts = 15-minute lockout)

### 6.2 Task Management Endpoints

```
GET    /api/v1/tasks
POST   /api/v1/tasks
GET    /api/v1/tasks/{id}
PUT    /api/v1/tasks/{id}
DELETE /api/v1/tasks/{id}
POST   /api/v1/tasks/{id}/verify
```

**Test Cases:**
- [ ] RBAC enforcement (NURSE can read, DOCTOR can create/update)
- [ ] Department-based isolation (users see only their department's tasks)
- [ ] PHI exposure in responses
- [ ] SQL injection via task fields
- [ ] Mass assignment vulnerabilities
- [ ] IDOR (Insecure Direct Object Reference)

### 6.3 EMR Integration Endpoints

```
POST /api/v1/emr/patient/{id}
POST /api/v1/emr/verify/epic
POST /api/v1/emr/verify/cerner
GET  /api/v1/emr/sync/status
```

**Test Cases:**
- [ ] OAuth2 token validation
- [ ] SMART-on-FHIR authorization bypass
- [ ] EMR data injection via FHIR payloads
- [ ] HL7 message parsing vulnerabilities
- [ ] XML/JSON injection attacks
- [ ] Patient ID enumeration

### 6.4 Audit Log Endpoints

```
GET /api/v1/audit-logs
GET /api/v1/audit-logs/{id}
```

**Test Cases:**
- [ ] Admin-only access enforcement
- [ ] Audit log tampering attempts
- [ ] PHI exposure in audit logs
- [ ] Pagination bypass
- [ ] Timestamp manipulation

---

## 7. KNOWN VULNERABILITIES (PRE-TEST)

### 7.1 Previously Identified Issues (From Forensics)

**‚úÖ RESOLVED (Phase 1):**
1. ~~Hardcoded database password in git history~~ ‚Üí Removed via BFG
2. ~~Client secret in HTTP headers~~ ‚Üí Fixed OAuth2 implementation
3. ~~TLS 1.2 instead of 1.3~~ ‚Üí Upgraded to TLS 1.3
4. ~~CORS wildcard (*)~~ ‚Üí Configured specific origins
5. ~~Missing field-level encryption~~ ‚Üí Implemented AES-256-GCM

**‚ö†Ô∏è TO BE VERIFIED:**
1. Vault integration for secrets management
2. 90-day key rotation implementation
3. All service entry points functional
4. Health check implementations complete

### 7.2 Areas of Concern

**High-Risk Areas:**
1. **EMR OAuth2 Flow** - Complex integration with Epic/Cerner
2. **CRDT Conflict Resolution** - Potential for data inconsistencies
3. **WebSocket Security** - Real-time sync authentication
4. **Mobile API Endpoints** - If different from web API

---

## 8. TEST ACCOUNTS

### 8.1 Staging Environment Credentials

**Will be provided separately via secure channel (1Password)**

**Test User Roles:**
- NURSE (read-only tasks)
- DOCTOR (create/update tasks)
- SUPERVISOR (department management)
- ADMINISTRATOR (full system access)

**Test Data:**
- 100 sample tasks with synthetic PHI
- 10 sample patients (FHIR resources)
- Audit log entries (7 days of data)

---

## 9. ACCEPTANCE CRITERIA

### 9.1 Pass/Fail Criteria

**PASS if:**
- ‚úÖ Zero CRITICAL vulnerabilities
- ‚úÖ Zero HIGH vulnerabilities related to PHI exposure
- ‚úÖ Rate limiting functional (no bypass)
- ‚úÖ All HIPAA technical safeguards verified
- ‚úÖ Authentication/authorization properly enforced
- ‚úÖ No SQL injection or XSS vulnerabilities

**FAIL if:**
- ‚ùå Any CRITICAL vulnerability found
- ‚ùå PHI accessible without authorization
- ‚ùå Authentication bypass possible
- ‚ùå Privilege escalation possible
- ‚ùå Audit log tampering possible

### 9.2 Severity Classification

**CRITICAL (P0):**
- PHI data breach potential
- Authentication bypass
- Remote code execution
- SQL injection with PHI access

**HIGH (P1):**
- Privilege escalation
- CSRF on critical actions
- Insecure cryptographic storage
- Broken access control

**MEDIUM (P2):**
- XSS vulnerabilities
- Information disclosure (non-PHI)
- Rate limiting bypass
- Insecure session management

**LOW (P3):**
- Security misconfigurations
- Verbose error messages
- Missing security headers
- Outdated dependencies

---

## 10. REPORTING REQUIREMENTS

### 10.1 Deliverables

**Required Reports:**
1. **Executive Summary** (2 pages max)
   - Overall security posture assessment
   - Critical findings summary
   - HIPAA compliance status
   - Go/No-Go recommendation

2. **Technical Report** (detailed)
   - Methodology and tools used
   - Detailed vulnerability descriptions
   - Proof-of-concept exploits
   - Evidence (screenshots, logs)
   - Remediation recommendations with code examples

3. **Compliance Matrix**
   - HIPAA 164.312 compliance checklist
   - OWASP Top 10 coverage
   - CWE mappings

4. **Remediation Plan**
   - Prioritized action items
   - Estimated remediation time
   - Verification checklist

### 10.2 Reporting Timeline

- **Day 5:** Initial findings presentation
- **Day 7:** Draft technical report
- **Day 10:** Final report delivery
- **Week 17:** Remediation verification report

---

## 11. RULES OF ENGAGEMENT

### 11.1 Authorization

**Authorized Activities:**
- ‚úÖ Scanning and enumeration of staging environment
- ‚úÖ Exploitation of discovered vulnerabilities
- ‚úÖ Privilege escalation attempts
- ‚úÖ Data exfiltration simulation (with test data only)

**Reporting Requirements:**
- üö® **IMMEDIATE** report any CRITICAL finding (< 1 hour)
- ‚ö†Ô∏è **URGENT** report HIGH findings (< 4 hours)
- üìã **STANDARD** report MEDIUM/LOW findings (daily summary)

### 11.2 Constraints

**Do NOT:**
- ‚ùå Test production environment
- ‚ùå Perform DoS/DDoS attacks
- ‚ùå Access real patient data (use test data only)
- ‚ùå Exfiltrate data outside staging network
- ‚ùå Share findings with third parties
- ‚ùå Test outside agreed timeline

### 11.3 Emergency Contacts

**Security Team:**
- Security Lead: security@emrtask.com (24/7 PagerDuty)
- DevOps Lead: devops@emrtask.com
- CTO: cto@emrtask.com

**Escalation:**
- CRITICAL findings: Call CTO immediately
- Service disruption: Contact DevOps Lead

---

## 12. SUCCESS METRICS

### 12.1 Coverage Metrics

**Target Coverage:**
- 100% of external endpoints tested
- 100% of authentication flows tested
- 100% of RBAC permutations tested
- 100% of PHI data paths verified
- 100% of HIPAA technical safeguards verified

### 12.2 Quality Metrics

**Expected Outcomes:**
- Comprehensive vulnerability assessment
- HIPAA compliance verification
- Actionable remediation guidance
- Risk-based prioritization
- Clear Go/No-Go recommendation for production

---

## 13. APPENDICES

### Appendix A: HIPAA Technical Safeguards Checklist

```
[ ] ¬ß164.312(a)(1) - Access Control
[ ] ¬ß164.312(a)(2)(i) - Unique User Identification
[ ] ¬ß164.312(a)(2)(ii) - Emergency Access Procedure
[ ] ¬ß164.312(a)(2)(iii) - Automatic Logoff
[ ] ¬ß164.312(a)(2)(iv) - Encryption and Decryption
[ ] ¬ß164.312(b) - Audit Controls
[ ] ¬ß164.312(c)(1) - Integrity
[ ] ¬ß164.312(d) - Person or Entity Authentication
[ ] ¬ß164.312(e)(1) - Transmission Security
[ ] ¬ß164.312(e)(2)(i) - Integrity Controls
[ ] ¬ß164.312(e)(2)(ii) - Encryption
```

### Appendix B: OWASP API Security Top 10 Checklist

```
[ ] API1:2023 - Broken Object Level Authorization
[ ] API2:2023 - Broken Authentication
[ ] API3:2023 - Broken Object Property Level Authorization
[ ] API4:2023 - Unrestricted Resource Consumption
[ ] API5:2023 - Broken Function Level Authorization
[ ] API6:2023 - Unrestricted Access to Sensitive Business Flows
[ ] API7:2023 - Server Side Request Forgery
[ ] API8:2023 - Security Misconfiguration
[ ] API9:2023 - Improper Inventory Management
[ ] API10:2023 - Unsafe Consumption of APIs
```

### Appendix C: Sample Test Cases

**SQL Injection Test:**
```bash
POST /api/v1/tasks
Authorization: Bearer <JWT_TOKEN>
Content-Type: application/json

{
  "title": "Test' OR '1'='1",
  "description": "'; DROP TABLE tasks; --",
  "patientId": "12345"
}
```

**JWT Token Tampering:**
```bash
# Original JWT
eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJ1c2VySWQiOiIxMjM0NTY3ODkwIiwicm9sZSI6Ik5VUlNFIn0.signature

# Tampered (role=ADMIN)
eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJ1c2VySWQiOiIxMjM0NTY3ODkwIiwicm9sZSI6IkFETUlOIn0.newsignature
```

**IDOR Test:**
```bash
# As Nurse (userIdA123), try to access task from different department
GET /api/v1/tasks/task-userIdB456-001
Authorization: Bearer <NURSE_JWT>
```

---

**Document prepared by:** Security Architecture Team
**Reviewed by:** CTO, Compliance Officer
**Approved for external testing:** Pending Week 14 completion

**Version History:**
- v1.0.0 (2025-11-11): Initial scope definition
